SCHEMBL23818992

SCHEMBL23818992

CCC(CC)COC(=O)[C@H](C)NP(=O)(OCc1ccccc1)OCC(C#N)(OC)[C@@H](OC(=O)C(C)C)[C@@H](OC(=O)C(C)C)c1ccc2c(N)ncnn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26336893 1.00 — —
SCHEMBL23819050 0.93 RIPK1 (0.32) —
SCHEMBL26345083 0.92 BTN3A1 (0.34) —
SCHEMBL23818947 0.90 RIPK1 (0.31) —
SCHEMBL23819343 0.89 — —
SCHEMBL26333768 0.89 — —
SCHEMBL23819096 0.86 BTN3A1 (0.35) —
SCHEMBL26334498 0.85 — —
SCHEMBL23819315 0.84 BTN3A1 (0.34) —
SCHEMBL23819003 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210284670-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-16 — — US disclosed
Send feedback